Dermatological Drugs Market (By Indication: Acne, Psoriasis, Rosacea, Alopecia) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

Published Date : May 2022 | No. of Pages : 150+ Pages | Category : Healthcare

The global dermatological drugs market was surpassed at USD 17.1 billion in 2021 and is expected to hit around USD 36.5 billion by 2030, growing at a CAGR of 8.79% from 2022 to 2030.

Dermatological Drugs Market Size 2021 to 2030

The global dermatological drugs market is expected to grow due to driving factors such as the availability of medical resources for detecting and treating skin diseases, nutritional deficiency due to unhealthy food habits, increasing awareness when it comes to lifestyle diseases, and increasing pollution levels, and lack of immunity in the population. Additionally, the rising per capita income and the increasing purchasing power are the driving forces in this market.

The acne segment is expected to expand with a CAGR of 10.5% from 2022 to 2028. Acne is a skin condition where dead skin and oil glands of skin glands are clogged, forming spots, pimples, and sometimes cysts. Additionally, infected hair follicles cause acne, which starts from the skin’s pores. Acne causes bumps on the face, shoulders, chest, and back in the form of pimples, blackheads, and whiteheads. Acne can be cured, and the appearance of the skin can be improved with effective treatment from dermatologists, contributing to the dermatological drug market.

North America held the largest revenue share of more than 35% in 2021. The U.S. is positively contributing to the growth of the regional market. The presence of well-established pharmaceutical vendors is one of the key factors supporting the market growth. This region is one of the promising regions to launch new technology in terms of healthcare infrastructure and advanced research and development activities that help innovate and produce the most appropriate drugs to cure cancer. It is observed that in the region, there is a rapid shift in the healthcare industry to consumer-driven from traditional treatment for providing diagnosis and provision-based health services. Additionally, ease of availability of drugs and reimbursement policies for the patient in the healthcare industry contributes to driving the market in the region.

Scope of The Report

Report Coverage Details
Market Size in 2021 USD 17.1 billion
Revenue Forecast by 2030 USD 36.5 billion
Growth rate from 2022 to 2030 CAGR of 8.79%
Base Year 2021
Forecast Period 2022 to 2030
Segmentation  Indication, region
Companies Covered Novartis AG, Amgen Inc, AbbVie Inc, Johnson & Johnson, Leo Pharma A/S, Eli Lilly and Company, GlaxoSmithKline Plc, AstraZeneca plc, Pfizer Inc, Merck KGaA

 

Indication Insights

The psoriasis segment dominated the market with a revenue share of more than 35.0% in 2021 and is expected to expand with the highest CAGR of 11.5% from 2022 to 2028. Psoriasis is caused by the immune system mistakenly attacking healthy skin cells. Psoriasis is not a contagious disease. The disease causes swollen fingers and toes, foot pain, lower back pain, nail changes, and eye inflammation. Psoriasis can be triggered by stress, skin injury, infections, some drugs, and heavy drinking. Psoriasis is found in all age groups but is majorly seen in adults and contributes to the global dermatology drug revenue.

The alopecia segment is likely to expand with the second-highest CAGR of 10.9% from 2022 to 2028. Alopecia caused due to the body’s immune system attacking hair follicles resulting in hair loss. Alopecia is an autoimmune disorder that results in hair coming out. Both men and women suffer from Alopecia due to an imbalance of hormones, hair care treatments, scalp infections, and possible side effects of some medications. Additionally, hereditary hair loss is the most common cause of hair loss globally. Citizens are careful about hair loss and visit hospitals for diagnosis. Hair loss requires ongoing treatments for a long period and contributes to the market growth rate.

Regional Insights

Asia Pacific is likely to expand at the highest CAGR of 12.2% from 2022 to 2028. Countries such as China and India, with the largest populations in the world, are expected to have many patients with skin diseases during the forecast period. Continuous improvement in the life science industry and health services and the awareness of skin diseases and their treatment are factors contributing to the highest growth of this market. Moreover, increasing incomes and the purchasing power of citizens are witnessing a significant growth rate in this market.  

Europe held the second-largest revenue share of more than 30.0% in 2021 and is expected to continue with a growth of 11% during the forecast period. Factors such as increasing large investment in the healthcare sector, greater prevalence of healthcare insurance among the masses, and supportive regulatory frameworks of the pharmaceutical industry in this region are attributed to the market revenue generation.

Key Players

  • Novartis AG
  • Amgen Inc
  • AbbVie Inc
  • Johnson & Johnson
  • Leo Pharma A/S
  • Eli Lilly and Company
  • GlaxoSmithKline Plc
  • AstraZeneca plc
  • Pfizer Inc
  • Merck KGaA

Market Segmentation

  • By Indication Outlook
    • Acne
    • Psoriasis
    • Rosacea
    • Alopecia
    • Others
  • By Regional Outlook
    • North America
      • U.S.
    • Europe
      • Germany
      • France
      • U.K.
    • Asia Pacific
      • China
      • India
    • Central & South America
      • Brazil
    • Middle East & Africa
      • South Africa

Featured Research Reports

  • Featured Research Reports

    Trauma Care Centers Market (By Facility Type: In-house, Standalone; By Trauma Type: Falls, Traffic-related Injuries; By Service Type) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Monkeypox Vaccine And Treatment Market (By Product: Vaccine, Drugs) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Hyaluronic Acid Market (By Application: Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    AI in Oncology Market (By Treatment: Chemotherapy, Radiotherapy, Immunotherapy, Targeted Therapy, Gene Therapy; By Cancer Type; By Application) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Paracetamol IV Market (By Application: Surgical, Non-surgical; By Indication: Pyrexia, Pain; By End-use: Hospitals, Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...